High-Performance Treatment for Pharmaceutical & Life Science Wastewater
Pharmaceutical and life science manufacturing produces complex wastewater containing active pharmaceutical ingredients, solvents, intermediates, and high-strength organic compounds. These waste streams require specialized biological treatment capable of degrading recalcitrant compounds while meeting stringent effluent discharge limits.
FibrePlate MBR technology excels in pharmaceutical wastewater applications where conventional treatment systems struggle. The membrane barrier ensures complete solids separation, enabling higher biomass concentrations that improve degradation of difficult-to-treat compounds common in pharmaceutical manufacturing.
From API manufacturing and fermentation processes to formulation and packaging facility wastewater, the Fibracast MBR System provides the treatment reliability and effluent consistency that pharmaceutical and biotech operations demand for regulatory compliance.
Reduced Footprint
The Fibracast MBR System delivers high-performance treatment within compact footprints, ideal for space-constrained industrial facilities.
Operational Stability
Engineered for variable flows, shifting production schedules, and evolving influent chemistries without fouling instability or transmembrane pressure (TMP) volatility.
Lifecycle Cost Control
Designed for decades of reliable infrastructure performance with predictable maintenance costs and reduced operator intervention over time.
Proven Performance
Field-validated across municipal and industrial applications with documented case studies, performance data, and third-party quality assurance.
